The National Institutes of Health (NIH) gave the U of M a $51 million grant, which will support medical programs that aim to get treatments, therapies, and clinical trial outcomes to patients faster.
The University of Minnesota recently received a $51 million grant that it will use to support both new and existing programs that are designed to push new treatments, therapies, and clinical trial outcomes to patients faster—thus offering more immediate benefits from discoveries.
The award was given to the U by the National Institutes of Health (NIH) and is the largest single-institution NIH award that the university has ever received.
With the award, the U joins the Clinical and Translational Science Award consortium, a national network of institutions working to increase joint research efforts between universities and the community and boost the efficiency and speed at which the results of clinical trials translate into new treatments, cures, and improved health outcomes.
Aaron Friedman, vice president for health sciences and dean of the U’s medical school, said in a press release that the grant will also be used to tie together research taking place across focus areas known as the university’s “Corridors of Discovery:” cancer, cardiology, diabetes, infectious diseases, and brain sciences.
“With this distinguished grant award, the NIH recognizes the strength of our university’s clinical research enterprise and our extraordinary capacity to translate scientific breakthroughs into improved health and well-being,” Friedman said in a statement.
Four other universities also received awards—which together totaled $200 million—including Pennsylvania State University's Milton S. Hershey Medical Center; University of California, Los Angeles; University of Kansas Medical Center; and the University of Kentucky, Lexington.
Including the five just-announced grants, the NIH is funding 60 institutions through its awards program.